Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 2;18(1):161.
doi: 10.1186/s13014-023-02251-2.

May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy?

Affiliations

May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy?

Ciro Mazzarella et al. Radiat Oncol. .

Abstract

Purpose: One of the main limiting factors of whole-brain radiation therapy (WBRT) for primary central nervous system lymphoma (PCNSL) is the impairment of neurocognitive functions (NCFs), which is mainly caused by radiation-induced injury to the hippocampus. With a view to preventing NCF impairment and personalizing treatment, we explored the feasibility of sparing the hippocampus during WBRT by correlating the sites of PCNSL lesions with the hippocampus.

Methods and materials: Pre-treatment MR images from patients who underwent WBRT between 2010 and January 2020-and post-radiotherapy images in cases of relapse-were imported into the Varian Eclipse treatment-planning system and registered with the simulation CT. We constructed three 3-dimensional envelopes around the hippocampus at distances of 5, 10 and 15 mm and also contoured primary lesions and recurrences.

Results: We analyzed 43 patients with 66 primary lesions: 9/66 (13.6%) involved the hippocampus and 11/66 (16.7%) were located within 5 mm of it. Thirty-six lesions (54.5%) were situated more than 15 mm from the hippocampus, while 10/66 (15.2%) were between 5 and 15 mm from it. The most common location was in deep brain structures (31%). Thirty-five of the 66 lesions relapsed: in field in 14/35 (40%) and outfield in 21/35 (60%) in different sites. Globally, 16/35 recurrences (45.7%) were located in the hippocampus or within 5 mm of it.

Conclusion: These data show that routinely sparing the hippocampus is not feasible. This approach could be considered in selected patients, when the lesion is more than 15 mm from the hippocampus.

Keywords: Hippocampal sparing; IMRT; Neuro-toxicity; PCNSL; Personalized treatment; WBRT.

PubMed Disclaimer

Conflict of interest statement

I haven’t Competing interests.

Figures

Fig. 1
Fig. 1
Contouring of hippocampus with 5-, 10-, and 15-mm expansion envelopes and lesion. (Yellow lines = hippocampus – Green lines = 5 mm envelope – Pink lines = 10 mm envelope – Blue lines = 15 mm envelope – Red lines = lesion)
Fig. 2
Fig. 2
Location of lesions on diagnosis as a function of distance from the hippocampus
Fig. 3
Fig. 3
Location of recurrences as a function of distance from the hippocampus

References

    1. Mufti ST, Baeesa SS, Al-Maghrabi JA. Primary intracranial lymphomas asian. J Neurosurg. 2016;11(3):232–9. doi: 10.4103/1793-5482.145082. - DOI - PMC - PubMed
    1. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2016;17(suppl_4):iv1–iv62. doi: 10.1093/neuonc/nov189. - DOI - PMC - PubMed
    1. Ferreri AJ, Reni M, Foppoli M, et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 2009;374:1512–20. doi: 10.1016/S0140-6736(09)61416-1. - DOI - PubMed
    1. Gavrilovic IT, Hormigo A, Yahalom J, De Angelis LM, Abrey LE. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006;24(28):4570–4. doi: 10.1200/JCO.2006.06.6910. - DOI - PubMed
    1. De Angelis LM, Iwamoto FM. An update on therapy of primary central nervous system lymphoma. Hematol Am Soc Hematol Educ Program. 2006;1:311–6. doi: 10.1182/asheducation-2006.1.311. - DOI - PubMed

MeSH terms